Udai Banerji Selected Research

Fulvestrant (Faslodex)

4/2021	Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer.
1/2020	Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Udai Banerji Research Topics

Disease

68	Neoplasms (Cancer) 05/2024 - 10/2003
10	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 10/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2015
6	Melanoma (Melanoma, Malignant) 10/2017 - 04/2008
5	Breast Neoplasms (Breast Cancer) 04/2021 - 08/2007
5	Disease Progression 01/2020 - 10/2015
4	Fatigue 11/2022 - 05/2012
4	Exanthema (Rash) 11/2020 - 02/2015
3	Neutropenia 01/2023 - 12/2006
3	Carcinoma (Carcinomatosis) 01/2023 - 05/2012
3	Diarrhea 11/2022 - 02/2015
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2023 - 05/2012
2	Pneumonia (Pneumonitis) 11/2022 - 01/2020
2	Nausea 11/2022 - 01/2014
2	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2016
2	Hypotension (Low Blood Pressure) 01/2020 - 01/2020
2	Hyperglycemia 01/2020 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 08/2018 - 10/2017
1	Inflammation (Inflammations) 11/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2023
1	Urticaria (Hives) 01/2023
1	Acidosis 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Anemia 11/2022
1	Cough 11/2022
1	Febrile Neutropenia 01/2022
1	Fever (Fevers) 11/2021
1	Multiple Myeloma 11/2020
1	Retinal Detachment (Retinal Detachments) 11/2020
1	Malignant Mesothelioma 01/2020
1	Mesothelioma 01/2020

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2005
10	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2007
10	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023 - 10/2003
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2021 - 09/2012
8	tanespimycin (17AAG)IBA 11/2018 - 11/2003
6	capivasertibIBA 04/2021 - 07/2017
5	Phosphotransferases (Kinase)IBA 04/2021 - 07/2017
5	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 12/2006
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2012
4	PhosphoproteinsIBA 01/2022 - 01/2016
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 11/2017
3	vistusertibIBA 01/2023 - 08/2015
3	CreatinineIBA 11/2020 - 05/2012
3	Estrogen ReceptorsIBA 01/2020 - 08/2014
3	Cell-Free Nucleic AcidsIBA 07/2017 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2017
2	SRA737IBA 01/2023 - 01/2023
2	AntibodiesIBA 01/2023 - 01/2020
2	PlatinumIBA 01/2023 - 01/2020
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2022 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2020
2	Cetuximab (Erbitux)FDA Link 10/2021 - 01/2020
2	Fulvestrant (Faslodex)FDA Link 04/2021 - 01/2020
2	RO5126766IBA 11/2020 - 09/2012
2	AT13148IBA 01/2020 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 02/2016
2	Capsules (Microcapsules)IBA 01/2018 - 03/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2017 - 11/2003
2	Adenosine Triphosphate (ATP)IBA 12/2017 - 07/2017
2	Phosphorylcholine (Phosphocholine)IBA 12/2017 - 11/2003
2	Anaplastic Lymphoma KinaseIBA 01/2017 - 01/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016 - 01/2016
2	Pemetrexed (MTA)FDA Link 01/2016 - 01/2015
2	AZD 6244IBA 02/2015 - 03/2010
2	ErbB Receptors (EGF Receptor)IBA 01/2015 - 06/2013
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 08/2014 - 07/2013
2	Histone Deacetylase InhibitorsIBA 08/2013 - 05/2012
2	Histones (Histone)IBA 08/2013 - 05/2012
1	ceralasertibIBA 11/2023
1	Gemcitabine FDA Link 01/2023
1	TroponinIBA 01/2023
1	AntigensIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	ProteomeIBA 01/2023
1	AZD3965IBA 01/2023
1	Cyclooxygenase 1IBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Cytostatic AgentsIBA 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022
1	Thymidylate SynthaseIBA 11/2022
1	guadecitabineIBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2021
1	olaparibIBA 10/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020

Therapy/Procedure

20	Therapeutics 07/2023 - 03/2010
9	Drug Therapy (Chemotherapy) 01/2020 - 12/2006
2	Precision Medicine 01/2017 - 09/2009
1	Radiotherapy 01/2024
1	Immunomodulation 01/2022